Public Health, Published May 2016
Teens who avidly seek new and intense sensations are more likely to start using substances, but are not more likely to use them regularly within the next 3 years unless they also are prone to devalue distant consequences and act impulsively.
Treatment, Published May 2016
Treatment that combines use of Bp/Nx and memantine may enable young adults addicted to opioids establish lasting abstinence after a relatively brief course of medication-assisted therapy, a pilot trial suggests.
Narrative of Discovery, Published April 2016
Treatment, Published March 2016
Basic Science, Published March 2016
Basic Science, Published February 2016
Treatment, Published January 2016
Basic Science, Published January 2016
Giving mice a modified version of a naturally occurring gene blocks cocaine’s stimulant effects without affecting the animals’ physiological or metabolic health. The new evidence advances the proposed therapy a step closer to readiness for testing in people.
Prevention, Published December 2015
Long-Term Follow-Up of Medication-Assisted Treatment for Addiction to Pain Relievers Yields “Cause for Optimism”
Treatment, Published November 2015
In the first long-term follow-up of patients treated with buprenorphine/naloxone for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy.
Animation: Testing a Prospective Medication To Help People Avoid Relapse. Watch Now
Animation: The Rise and Fall of the Cocaine High. Watch Now